Every coronavirus vaccine so far has shown us SOME defect upon mass release, which was NOT evident in EVEN phase III clinical trials.
Look HERE for a searchable PDF document of adverse effects from the Pfizer vaccine:
Check out these videos on the low-platelet clotting problem from the Oxford/Astrazeneca vaccine.
Here is a fantastic explanation of the AstraZeneca problem and what people are doing about it.
You will note that Dr. ZDogg, MD points the J+J vaccine being at risk of having the same clotting problem as the AstraZeneca vaccine, due to them BOTH using DNA (as opposed to mRNA) and viral vector (as opposed to liposome) delivery technologies.
I just learned something today from C&EN that may impact this.
It turns out that Pfizer, Moderna and J+J are ALL using the “2P mutation” of the spike protein, but AstraZeneca is not. This mutation significantly CHANGES the spike protein, preventing it from leaving the “pre-attack” molecular shape.
Is THAT the difference? Does the 2P mutation prevent the spike protein from causing problems? Stay tuned! The J+J vaccine will get intense scrutiny going forward.
Now – J+J has had a problem of being WEAK from the very beginning, but STATISTICALLY it has still shifted people AWAY from being hospitalized or dying. People may have still caught the disease after vaccination, but they were never going to the hospital or dying – a LOT like hydroxychloroquine administered early, or better still, the Zelenko protocol.
A short while back, one gal in New York got COVID about a month after getting J&J.
She was not hospitalized. This was a living example of the admitted weakness of the J+J vaccine. NOW, however, somebody who got J+J DID get COVID and DID go to the hospital, so the “promise” you will not go to the hospital with the J+J vaccine just got a bit weaker.
Will J+J go to a 2-shot booster program? Hmmmmmm.
My bottom line?
I like waiting for the results to come in from the PHASE IV “Hold My Beer” TRIALS. Particularly since I’ve already HAD the disease.